Therefore, we conducted a retrospective study to determine the frequency and prognostic significance of TEL-AML1 fusion in CD 10 positive B-ALL, and to clarify whether the persistence of the TEL-AML1 fusion gene as a MRD has an additive value. Here, RUNX1 is linked to acute lymphoblastic leukemia.